Media Outlets Continue Coverage Of Trump Administration’s Lawsuit Against Gilead Over Patent Infringements On PrEP Medicines

Axios: Federal lawsuit against Gilead puts patent rights on trial (Herman, 11/8).

Financial Times: U.S. sues Gilead over HIV patent infringements (Mancini, 11/7).

The Hill: Trump administration sues HIV prevention drug maker for patent infringement (Sullivan, 11/7).

STAT: HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills (Silverman, 11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.